Effect of amyloid β‐peptide on permeability transition pore: A comparative study
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
A potentially central factor in neurodegeneration is the permeability transition pore (PTP). Because of the tissue‐specific differences in pore properties, we directly compared isolated brain and liver mitochondria responses to the neurotoxic Aβ peptides. For this purpose, the following parameters were examined: mitochondrial membrane potential (ΔΨm), respiration, swelling, ultrastructural morphology, and content of cytochrome c. Both peptides, Aβ 25–35 (50 μM) and Aβ 1–40 (2 μM), had a similar toxicity, exacerbating the effects of Ca 2+, although, per se, they did not induce (PTP). In liver mitochondria, Aβ led to a drop in ΔΨm and potentiated matrix swelling and disruption induced by Ca 2+. In contrast, brain mitochondria, exposed to the same conditions, demonstrated a higher capacity to accumulate Ca 2+ before the ΔΨm drop and a slight increase of mitochondrial swelling compared with liver mitochondria. Furthermore, mitochondrial respiratory state 3 was depressed in the presence of Aβ, whereas state 4 was unaltered, resulting in an uncoupling of respiration. In both types of mitochondria, Aβ did not affect the content of cytochrome c. The ΔΨm drop was reversed when Ca 2+ was removed by EGTA or when ADP plus oligomycin was present. Pretreatment with cyclosporin A or ADP plus oligomycin prevented the deleterious effects promoted by Aβ and/or Ca 2+. It can be concluded that brain and liver mitochondria show a different susceptibility to the deleterious effect of Aβ peptide, brain mitochondria being more resistant to the potentiation by Aβ of Ca 2+‐induced PTP. © 2002 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oxidative damage and mitochondrial decay in aging.
Shigenaga, M. K., Hagen, T. M., & Ames, B. N. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.10771 · Cited by 2,055 · cited 3×
“Mitochondrial oxidative damage is a major factor in many human disorders, including neurodegenerative diseases and aging (Shigenaga et al., 1994; Beal, 1995, 1996).”
BackgroundNeurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state
Pike, C., Burdick, D., Walencewicz, A., Glabe, C., & Cotman, C. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-04-01676.1993 · Cited by 1,417
Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.
Lorenzo, A., & Yankner, B. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12243 · Cited by 1,324
Hensley, K., Carney, J. M., Mattson, M. P., Aksenova, M., Harris, M., Wu, J. F., Floyd, R. A., & Butterfield, D. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3270 · Cited by 1,086 · cited 1×
“A itself has been shown to be a source of free radicals, probably because of distortions of the electronic structure of A , resulting in “radicalization” of the peptide (Hensley et al., 1994).”
BackgroundBroekemeier, K. M., Dempsey, M. E., & Pfeiffer, D. R. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83116-7 · Cited by 699 · cited 2×
“…by an abrupt swelling and depolarization of mitochondrial membrane, accompanied by the efflux of mitochondrial calcium, reduced glutathione (GSH), and NAD(P)H (Bernardi, 1992; Petronilli et al., 1994), which are inhibited by the immunosuppressant cyclosporin A (CsA) (Broekemeier et al., 1989).”
BackgroundPike, C. J., Walencewicz‐Wasserman, A. J., Kosmoski, J., Cribbs, D. H., Glabe, C. G., & Cotman, C. W. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64010253.x · Cited by 699 · cited 1×
“Several lines of evidence demonstrate that methionine 35 is the amino acid responsible for A peptide aggregation and neurotoxicity (Pike et al., 1995).”
BackgroundRegulation of oxidative phosphorylation in the mammalian cell
Balaban, R. S. (1990) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1990.258.3.c377 · Cited by 446 · cited 1×
“Moreover, the control of respiration in isolated mitochondria is well understood (Tager et al., 1983; Balaban, 1990).”
BackgroundPereira, C., Santos, M. S., & Oliveira, C. (1999) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0241 · Cited by 156 · cited 1×
“Pereira et al. (1999) showed, in PC12 cells, that A induces mitochondrial dysfunction and impairment of glycolysis, leading to ATP depletion, by a mechanism involving the generation of ROS.”
BackgroundSelf-citation
Cited by
Stefani, M., & Dobson, C. M. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0464-5 · Cited by 1,651
Reddy, P. H., & Beal, M. F. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.12.002 · Cited by 975
Du, H., Guo, L., Fang, F., Chen, D., A Sosunov, A., M McKhann, G., Yan, Y., Wang, C., Zhang, H., Molkentin, J. D., et al. (2008) · Nature Medicine · doi:10.1038/nm.1868 · Cited by 932
Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology
Moreira, P. I., Carvalho, C., Zhu, X., Smith, M. A., & Perry, G. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.10.006 · Cited by 734
Self-citationAbramov, A. Y., Canevari, L., & Duchen, M. R. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4042-03.2004 · Cited by 587
Rego, A. C., & Oliveira, C. R. (2003) · Neurochemical Research · doi:10.1023/a:1025682611389 · Cited by 472
Self-citationMitochondria: A therapeutic target in neurodegeneration
Moreira, P. I., Zhu, X., Wang, X., Lee, H.-G., Nunomura, A., Petersen, R. B., Perry, G., & Smith, M. A. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.10.007 · Cited by 285
Self-citationMitochondrial Dysfunction and Synaptic Transmission Failure in Alzheimer’s Disease
Guo, L., Tian, J., & Du, H. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160702 · Cited by 211
Mitochondrial alterations Alzheimer's disease
Baloyannis, S. J., Costa, V., & Michmizos, D. (2004) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/153331750401900205 · Cited by 206
Mitochondria as a centrally positioned hub in the innate immune response
Sandhir, R., Halder, A., & Sunkaria, A. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.10.020 · Cited by 135
Moreira, P. I., Santos, M. S., Moreno, A. M., Seiça, R., & Oliveira, C. R. (2003) · Diabetes · doi:10.2337/diabetes.52.6.1449 · Cited by 117
“Recently, we demonstrated that A and/or Ca(2) induce PTP opening of brain mitochondria (45,46).”
BackgroundSelf-citationHan, S.-H., Park, J.-C., & Mook-Jung, I. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.12.004 · Cited by 67
Effect of Streptozotocin‐Induced Diabetes on Rat Brain Mitochondria
Moreira, P. I., Santos, M. S., Moreno, A. M., Proença, T., Seiça, R., & Oliveira, C. R. (2004) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2004.1107.x · Cited by 47
Self-citationThe Cytotoxicity and Clearance of Mutant Huntingtin and Other Misfolded Proteins
Folger, A., & Wang, Y. (2021) · Cells · doi:10.3390/cells10112835 · Cited by 32
Metadata
- Authors
- Moreira, P. I., Santos, M. S., Moreno, A., Rego, A. C., & Oliveira, C.
- Venue
- Journal of Neuroscience Research
- Publisher
- Wiley
- Published
- 2002-05-24
- Volume
- 69
- Issue
- 2
- Pages
- 257-267
- ISSN
- 0360-4012 (ISSN-L)
- 1097-4547
- OpenAlex
- W2084724753
- Cited by
- 119
- References
- 8
- FWCI
- 1.73
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.